Kiromic Biopharma's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Kiromic Biopharma is scheduled to report earnings on May 10, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22
Income Statement	-
Total Revenue	-	-	-	$ 0.00	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -6.43M	$ -5.30M	$ -6.91M	$ -11.86M	$ -8.43M
EBITDA	$ -5.51M	$ -5.22M	$ -6.34M	$ -11.32M	$ -8.03M
Net Income Common Stockholders	$ -6.76M	$ -5.30M	$ -7.07M	$ -11.95M	$ -8.52M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 2.70M	$ 2.05M	-	$ 432.70K	$ 6.51M
Total Assets	$ 13.64M	$ 13.11M	-	$ 13.02M	$ 19.52M
Total Debt	$ 10.10M	$ 11.97M	$ 0.00	$ 2.17M	$ 2.42M
Net Debt	$ 7.40M	$ 9.91M	$ 0.00	$ 1.74M	$ -4.09M
Total Liabilities	$ 19.93M	$ 21.25M	-	$ 12.74M	$ 7.74M
Stockholders Equity	$ -6.29M	$ -8.14M	-	$ 284.10K	$ 11.78M
Cash Flow	-
Free Cash Flow	$ -6.46M	$ -4.13M	$ -4.14M	$ -5.96M	$ -8.44M
Operating Cash Flow	$ -6.46M	$ -4.13M	$ -4.10M	$ -6.10M	$ -5.97M
Investing Cash Flow	-	-	$ -42.20K	$ 132.40K	$ -2.47M
Financing Cash Flow	$ 7.11M	$ 5.54M	$ 4.36M	$ -114.90K	$ -170.80K

Currency in USD

Kiromic Biopharma Earnings and Revenue History

Income Statement >

Kiromic Biopharma Debt to Assets

Balance Sheet >

Kiromic Biopharma Cash Flow

Cash Flow >

Kiromic Biopharma Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing